Deucrava 6 mg (Deucravacitinib) Tablets

Deucrava 6 mg Tablet contains Deucravacitinib, an advanced oral medication belonging to the selective Tyrosine Kinase 2 (TYK2) inhibitor class. It is primarily prescribed for the treatment of moderate to severe plaque psoriasis in adult patients who are candidates for systemic therapy or phototherapy.

By targeting specific immune pathways involved in inflammatory processes, this medicine helps reduce the excessive immune response associated with psoriasis. Regular use may lead to noticeable improvements in skin appearance, reduction of plaques, and relief from common symptoms such as itching, redness, scaling, and discomfort.

Therapeutic Benefits:

• Helps manage moderate to severe plaque psoriasis.
• Reduces skin inflammation associated with immune-mediated conditions.
• Decreases redness, scaling, and thickened skin plaques.
• Helps improve skin clarity and overall skin health.
• May reduce itching and discomfort caused by psoriasis.
• Supports long-term disease control when used as prescribed.
• Targets specific inflammatory pathways while minimizing broader immune suppression.
• May improve quality of life and daily functioning in patients affected by chronic psoriasis.

Generic Name: Deucravacitinib

Active Ingredient:
Each film-coated tablet contains:

• Deucravacitinib INN 6 mg

Pharmacological Classification:

• Selective TYK2 (Tyrosine Kinase 2) Inhibitor
• Immunomodulatory Agent

Dosage Form:

• Film-Coated Tablet

Strength:

• 6 mg

Deucravacitinib works by selectively inhibiting TYK2, an intracellular signaling enzyme involved in the activity of cytokines associated with inflammatory and autoimmune disorders. Through selective TYK2 inhibition, it helps regulate immune responses linked to the development and progression of plaque psoriasis.

This targeted mechanism distinguishes it from broader immunosuppressive therapies and contributes to its therapeutic effectiveness in eligible patients.

The usual recommended dose is 6 mg once daily, taken orally or as directed by a registered healthcare professional.

Administration Instructions:

• Take one tablet once daily at the same time each day.
• Swallow the tablet whole with a sufficient amount of water.
• The medication may be taken with or without food.
• Do not crush, split, or chew the tablet unless specifically instructed by a healthcare provider.
• Continue treatment regularly for optimal therapeutic benefit.

Missed Dose Guidance:

• If a dose is missed, take it as soon as possible on the same day.
• If it is almost time for the next scheduled dose, skip the missed dose and resume the regular dosing schedule.
• Do not take two doses at the same time to compensate for a missed dose.

Special Considerations:

• Treatment should be initiated and monitored by a qualified physician experienced in managing psoriasis.
• Regular clinical assessments may be recommended to evaluate treatment response and safety.
• Patients should inform their healthcare provider about any existing medical conditions, ongoing treatments, or signs of infection before starting therapy.
• Dosage adjustments may be required in specific clinical situations based on individual patient needs and physician judgment.